Healthcare -
Biotechnology - NASDAQ - US
$ 684.01
0.136 %
$ 73.9 B
Market Cap
16.93
P/E
REGN - CASH FROM INVESTING ACTIVITIES
Cash from Investing Activities REGN - Regeneron Pharmaceuticals, Inc.
-3.19 B
LAST VALUE
23.09%
2 YEAR CAGR
-16.84%
5 YEAR CAGR
-24.52%
10 YEAR CAGR